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Abstract
Background: In comparison with open distal pancreatectomy (ODP), laparoscopic distal pancreatec-
tomy (LDP) is associated with fewer complications and shorter hospital stays, but comparative cost data
for the two approaches are limited.
Methods: Records of all distal pancreatectomies carried out from January 2009 to June 2013 were
reviewed and stratified according to operative complexity. Patient factors and outcomes were recorded.
Total variable costs (TVCs) were tabulated for each patient, and stratified by category [e.g. ‘floor’,
‘operating room’ (OR), ‘radiology’]. Costs for index admissions and 30-day readmissions were compared
between LDP and ODP groups.
Results: Of 153 procedures, 115 (70 LDP, 45 ODP) were selected for analysis. The TVC of the index
admission was US$3420 less per patient in the LDP group (US$10 480 versus US$13 900; P = 0.06).
Although OR costs were significantly greater in the LDP cohort (US$5756 versus US$4900; P = 0.02), the
shorter average hospitalization in the LDP group (5.2 days versus 7.7 days; P = 0.01) resulted in a lower
overall cost. The total cost of index hospitalization combined with readmission was significantly lower in
the LDP cohort (US$11 106 versus US$14 803; P = 0.05).
Conclusions: In appropriately selected patients, LDP is more cost-effective than ODP. The increased
OR cost associated with LDP is offset by the shorter hospitalization. These data clarify targets for further
cost reductions.
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Introduction
Since the first laparoscopic cholecystectomy was performed in
1985, minimally invasive techniques have gradually been
adopted in many abdominal surgical procedures.1 By using
smaller incisions, the laparoscopic approach results in improved
cosmesis, reduced postoperative pain, and quicker recovery for
many patients.2 Laparoscopic distal pancreatectomy (LDP) is the
most commonly performed minimally invasive resection involv-
ing the pancreas.3 Although it typically requires no anastomosis
and is usually less technically demanding than laparoscopic
pancreaticoduodenectomy, LDP still requires complex
retroperitoneal access, careful dissection and the avoidance of
injury to critical surrounding structures. The complexity of this
operation varies tremendously according to the patient’s body
habitus, tumour type, and tumour location within the gland.
Recent literature comparing the safety and efficacy of LDP with
those of open distal pancreatectomy (ODP) has demonstrated, in
well-selected patients, lower intraoperative blood loss, reduced
hospital length of stay (LoS) and decreased overall morbidity in
LDP cohorts.3–6 Although no randomized controlled trials com-
paring the two approaches have been conducted, retrospectiveThis manuscript was presented at the annual AHPBA meeting, Miami,
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comparisons suggest favourable postoperative outcomes in LDP
patients, including reduced times to first flatus, oral intake,
ambulation and weaning from i.v. pain medication, a decrease in
the number of 30-day hospital readmissions, and no increase in
the occurrence of postoperative pancreatic fistula (POPF).3,4,7
Large, multicentre analyses of oncologic parameters in LDP and
ODP have shown no significant differences in lymph node
retrieval, numbers of positive nodes, or margin positivity.8–10
The question of the cost-effectiveness of LDP versus ODP has
been investigated in a few small reports.2,7,11–14 The data from these
studies are mixed: there is a general consensus that the increased
operative costs of LDP outweigh the benefit derived from the
decreased hospital stay costs associated with the minimally inva-
sive procedure. Furthermore, much of these data come from
centres outside the USA, which makes extrapolation to domestic
practice difficult. In this era of increased awareness of the costs of
health care, issues not only of surgical safety and efficacy, but also
of associated expenditure, must be considered with prudence. To
explore this latter issue, a retrospective comparison of operative
and hospital costs for both LDP and ODP was conducted at the
Winship Cancer Institute, Emory University (Atlanta, GA, USA)
to determine if LDP is indeed cost-effective in comparison with
ODP.
Methods and materials
This study was compliant with Health Insurance Portability and
Accountability Act requirements and was approved by the Emory
University Institutional Review Board.
Patients
Records for all patients who underwent distal pancreatectomy
(DP) from January 2009 to June 2013 at Emory University Hos-
pital were retrospectively evaluated. Five experienced surgeons
competent in minimally invasive techniques performed all open
and laparoscopic resections. Cases were entered into a prospec-
tively managed electronic database and matched with hospital
‘encounter numbers’, which are unique identifiers that correspond
to each patient’s entire hospital stay, allowing for compilation of
cost information. Patients with both benign and malignant
disease of the pancreas were included in the study. Routine blood
tests and preoperative imaging, where appropriate, were per-
formed. Prior to surgery, cases were presented to a multidiscipli-
nary gastrointestinal tumour board consisting of surgeons,
radiologists, medical oncologists, radiation oncologists and gas-
troenterologists. Patients were assessed for operative indications
and feasibility, probability of operative success, and likelihood of
recovery, prior to proceeding to surgery.
Definitions
Distal pancreatectomy was defined as a head-preserving formal
pancreatic resection, with or without splenectomy. Both LDP and
ODP were defined according to the surgical technique employed.
In some LDP cases, a hand-assisted method was used according to
surgeon preference. Patients in this study were further stratified by
operative complexity as determined independently by two of the
authors. ‘Standard’ complexity cases included resections of the
distal pancreas with or without splenectomy, and with or without
cholecystectomy. ‘High’ complexity cases involved additional
organ resection beyond the gallbladder (stomach, colon, kidney,
etc.) and were excluded from this analysis. More extensive resec-
tions of the pancreas (subtotal pancreatectomy or total pancrea-
tectomy) or partial resections (enucleations) were also excluded.
Conversions to an open procedure in which only the distal
pancreas, spleen or gallbladder were removed were considered to
represent cases of ‘standard’ complexity in keeping with an intent-
to-treat analysis, but cases in which other organs were removed
were excluded. Postoperative complications were classified using
the previously described Clavien–Dindo scoring system.15 The
Charlson comorbidity index for each patient was calculated retro-
spectively to quantify comorbid conditions for analysis.16 The
presence of POPF was defined using the 2005 International Study
Group on Pancreatic Fistula (ISGPF) criteria of drain output of
any measurable volume on or after postoperative day 3 with an
amylase level of more than three times the upper normal serum
value.17 All POPF were further classified as Grade A, B or C;
fistulae of Grade B or C were denoted by the authors as ‘clinically
relevant’.
Operative technique
Detailed descriptions of the operative techniques used in LDP and
ODP have been described elsewhere.18,19
Data analysed
Demographic, operative and perioperative data were collected for
clinical comparison. Type of resection, intraoperative blood loss,
operative time, hospital LoS, postoperative morbidity, and 30-day
readmission rates were recorded.
Cost analysis
Cost data were acquired using unique ‘encounter numbers’ which
corresponded to each patient’s hospital stay. Total variable costs
(TVCs) were compared between the two approaches as this cost
metric provides the most accurate representation of direct hospi-
tal costs. For each patient, cost data were assessed by tabulating the
costs of care for the hospital stay [e.g. floor, intensive care unit
(ICU), operating room (OR), pharmaceutical, post-anaesthesia
care unit, laboratory and pathology, and radiology costs]. Floor
costs included nightly room expenses, food, wages and benefits for
nurses, allied health professionals (physiotherapists, occupational
therapists, rehabilitation services), and administrative staff, as well
as building operational expenses (for heating, water supply and
facilities management). Operating room costs included the costs
of operative time (calculated per minute) and supplies as recorded
using a computerized dispensing cabinet that corresponded to
each patient’s procedure (Pyxis ProcedureStation System; Cardi-
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nal Health, Inc., Dublin, OH, USA). Costs of operative equipment
were also analysed, focusing on the usage of surgical staplers and
energy devices. Laboratory and pharmaceutical costs were col-
lected on a per-order basis. Similar data collection occurred for
other categories. Costs were not adjusted for inflation. The TVCs
for both the index admission and any 30-day hospital readmis-
sions were considered for analysis.
Statistical analysis
Statistical analysis was performed using IBM spss Statistics for
Windows Version 21 (IBM Corp., Armonk, NY, USA). Differences
in means between groups were compared using an independent-
samples t-test. Categorical variables were analysed using the chi-
squared test. Statistical significance was defined by a P-value of
<0.05.
Results
Demographics and clinical outcomes
During the period from January 2009 to June 2013, of a total of
153 cases, 115 ‘standard complexity’ DP procedures were per-
formed at the study institution; 70 of these were laparoscopic
resections. Demographic and clinicopathologic characteristics of
the patient population are presented in Table 1. There were no
significant differences between the LDP and ODP cohorts in
patient age, gender, body mass index, Charlson comorbidity score,
American Society of Anesthesiologists (ASA) class or preoperative
laboratory values. The percentages of resections performed for
malignancy and for chronic pancreatitis were similar in both
groups.
Operating room
The average operative time was 9 min longer in the LDP group
(145 min versus 136 min; P = 0.44) and average blood loss was
significantly lower (113 ml versus 210 ml; P = 0.03) in the LDP
cohort (Table 2). Intraoperative blood transfusion was required in
only two patients, including one in each of the LDP and ODP
cohorts. Closed suction drains were placed intraoperatively in a
majority of patients in both the LDP and ODP groups. Average
tumour size was smaller in patients undergoing LDP, but the
difference was not significant (3.7 cm versus 4.7 cm; P = 0.26).
The length of pancreas resected did not differ between the two
groups. Nodal retrieval was similar among LDP and ODP
patients.
Table 1 Patient demographics and clinicopathologic characteristics
of standard complexity laparoscopic and open distal
pancreatectomies
Variable LDP (n = 70) ODP (n = 45) P-value
Age, years, mean ± SD 58.6 ± 13.5 56.3 ± 16.1 0.40
Male gender, n (%) 24 (34%) 21 (47%) 0.26
Body mass index, kg/m2,
mean ± SD
27.9 ± 7.0 27.7 ± 5.9 0.84
Charlson comorbidity index,
mean ± SD
1.79 ± 2.02 1.37 ± 1.67 0.26
ASA class, mean ± SD 2.57 ± 0.63 2.69 ± 0.51 0.36
Final pathology, n (%)
Adenocarcinoma 11 (16%) 8 (18%) 0.97
Neuroendocrine tumour 18 (26%) 11 (24%) 1.00
Serous/mucinous
cystadenoma
22 (31%) 8 (18%) 0.16
Intraductal mucinous 8 (11%) 3 (7%) 0.52
Chronic pancreatitis 8 (11%) 7 (16%) 0.72
Other (pseudopapillary
tumour, pseudocyst)
3 (4%) 8 (18%) 0.02
LDP, laparoscopic distal pancreatectomy; ODP, open distal pancreatec-
tomy; SD, standard deviation; ASA, American Society of Anesthesiolo-
gists.
Table 2 Intraoperative and postoperative results in standard com-
plexity laparoscopic and open distal pancreatectomies
LDP (n = 70) ODP (n = 45) P-value
Estimated blood loss, ml,
mean ± SD
113 ± 155 210 ± 274 0.03
Length of surgery, min,
mean ± SD
145 ± 61 136 ± 60 0.44
Intraoperative transfusion 1 (1%) 1 (2%) 0.75
Drains placed, n (%) 63 (90%) 40 (89%) 0.85
Hand assistance, n (%) 21 (30%) NA NA
Conversions to open, n (%) 5 (7%) NA NA
Tumour size, cm, mean ±
SD
3.73 ± 2.82 4.71 ± 4.63 0.26
Length of pancreas
removed, cm, mean ± SD
9.80 ± 3.09 10.56 ± 4.04 0.29
Number of nodes
dissected, mean ± SD
7.54 ± 7.91 9.02 ± 9.21 0.36
Number of positive nodes
(malignant cases only),
mean ± SD
0.33 ± 1.30 0.22 ± 0.74 0.62
Morbidity, n (%) 34 (49%) 27 (60%) 0.31
Severe morbidity (Clavien
score 3–5), n (%)
8 (11%) 8 (18%) 0.49
Clavien score for worst
complication, mean ± SD
1.73 ± 0.83 2.00 ± 1.11 0.29
Pancreatic fistula (all
grades), n (%)
25 (36%) 16 (36%) 0.99
Grade B/C fistula, n (%) 10 (14%) 6 (13%) 0.89
Hospital LoS, days, mean ±
SD
5.2 ± 2.4 7.7 ± 5.8 0.01
Hospital LoS, days, median
(range)
5 (1–18) 6 (2–30) NA
30-day readmission, n (%) 9 (13%) 8 (18%)- 0.29
P-values in bold indicate differences of statistical significance (P < 0.05).
LDP, laparoscopic distal pancreatectomy; ODP, open distal pancreatec-
tomy; SD, standard deviation; LoS, length of stay; NA, not applicable.
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Postoperative outcomes
Rates of postoperative morbidity were similar among LDP and
ODP patients (49% versus 60%; P = 0.31). Rates of major
complications (Clavien–Dindo Grades III–V) were similar
between the cohorts (11% versus 17%; P = 0.49). Most complica-
tions were minor and included prolonged nausea and vomiting,
fever, and electrolyte imbalance. The mean Clavien–Dindo score
for worst complication did not differ significantly between the
groups (1.7 versus 2.0; P = 0.29). Rates of any POPF (36% versus
36%; P = 0.99) and clinically significant Grade B or C POPF (14%
versus 13%; P = 0.89) were similar between the LDP and ODP
cohorts. Of patients with POPF, nine (five in the LDP and four in
the ODP cohort) required interventional radiology procedures to
drain fluid collections. There were no mortalities in the 30-day
postoperative period.
Hospital LoS was significantly shorter in the LDP group by 2.5
days (5.2 days versus 7.7 days; P = 0.01). Thirty-day readmission
rates were similar between the LDP and ODP cohorts (13% versus
18%; P = 0.29).
Cost analysis
The TVC for the entire index hospital stay was lower in the LDP
group than the ODP group by US$3420 (US$10 480 versus
US$13 900; P = 0.06) per patient. Cost analysis (Table 3) demon-
strated that although the operative costs of laparoscopic cases
were significantly higher (US$5760 ± 1890 versus US$4900 ±
1790; P = 0.02), these increased costs were offset by decreased floor
(US$2590 ± 1250 versus US$3780 ± 2230; P < 0.01), laboratory
and pathology (P = 0.02), pharmacology (P = 0.02), radiology
(P = 0.08) and ICU costs (P = 0.15). When total costs of index
hospital admissions and readmissions were taken into account,
LDP was found to be associated with significantly lower TVCs
than ODP (US$11 110 ± 4220 versus US$14 800 ± 11 920;
P = 0.05).
A detailed analysis of OR-related costs revealed that operative
time-related TVCs were similar between the two cohorts
(US$1310 ± 490 versus US$1190 ± 540; P = 0.22). In the present
series, energy devices [the Harmonic Scalpel (Ethicon Endo-
Surgery, Inc., Cincinnati, OH, USA) and the Autosonix Ultrasonic
Surgical System (Covidien, Inc., Mansfield, MA, USA)] were used
in 100% of LDP procedures but in only 49% of ODP procedures
(P < 0.01) (Table 4). The cost of using these devices in LDP in
comparison with ODP (US$850 ± 363 versus US$330 ± 360; P <
0.01) contributed to the significantly greater total OR costs
accrued in the LDP cohort. Compared with LDP,ODP procedures
made more frequent use of surgical staplers (P = 0.001) and
employed a higher number of stapler reloads (P < 0.01). Despite
the lower overall TVC, the use of staplers and their reloads repre-
sented the principle contributor to ODP TVC (US$2080 ± 1180
versus US$1270 ± 590; P < 0.01).
Laparoscopic hand assistance
In 21 (30%) laparoscopic procedures a hand-assist approach was
utilized. Intraoperative, postoperative and cost outcomes were
compared between pure LDP and LDP with hand assistance
(LHDP) (Table 5). Intraoperatively, LDP was associated with sig-
nificantly less blood loss (76 ml versus 197 ml; P = 0.04) and
resection of smaller tumours (3.07 cm versus 5.15 cm; P < 0.01)
compared with LHDP. The remaining operative and postoperative
Table 3 Cost comparison of standard complexity laparoscopic and
open distal pancreatectomies
Cost, US$, mean ± SD
LDP (n = 70) ODP (n = 45) P-value
TVC for index hospital
stay
10 480 ± 2970 13 900 ± 11 600 0.06
Floor TVC 2590 ± 1250 3780 ± 2230 <0.01
Operating room TVC 5760 ± 1890 4900 ± 190 0.02
Laboratory/pathology
TVC
790 ± 430 1170 ± 1000 0.02
Pharmacology TVC 720 ± 380 1660 ± 2550 0.02
Radiology TVC 120 ± 390 670 ± 2060 0.08
Intensive care unit
TVC
170 ± 770 1310 ± 5160 0.15
TVC for index +
readmission: all
patients
11 110 ± 4220 14 800 ± 11 920 0.05
P-values in bold indicate differences of statistical significance (P < 0.05).
SD, standard deviation; LDP, laparoscopic distal pancreatectomy; ODP,
open distal pancreatectomy; TVC, total variable costs.
Table 4 Cost comparison for use of operative equipment in
laparoscopic and open distal pancreatectomies
LDP (n = 70) ODP (n = 45) P-value
Operating room equipment
TVC, US$, mean ± SD
3370 ± 1720 2540 ± 1320 <0.01
Energy device use, n (%) 70 (100%) 22 (49%) <0.01
Energy devices TVC, US$,
mean ± SD
850 ± 360 330 ± 370 <0.01
Surgical stapler use, n (%) 69 (99%) 44 (98%) 1.00
Surgical staplers TVC, US$,
mean ± SD
520 ± 280 780 ± 480 <0.01
Staple reload TVC, US$,
mean ± SD
740 ± 450 1300 ± 940 <0.01
Surgical stapler + reloads
TVC, US$, mean ± SD
1270 ± 590 2080 ± 1180 <0.01
Devices + surgical staplers
(including reloads) TVC,
US$, mean ± SD
2120 ± 760 2410 ± 1210 0.15
Operating room time TVC,
US$, mean ± SD
1310 ± 490 1190 ± 540 0.22
Operating room, TVC, US$,
mean ± SD
5760 ± 1890 4900 ± 1790 0.02
P-values in bold indicate differences of statistical significance (P < 0.05).
LDP, laparoscopic distal pancreatectomy; ODP, open distal pancreatec-
tomy; TVC, total variable costs; SD, standard deviation.
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factors, including morbidity, fistula incidence, hospital LoS and
30-day readmission rate, were similar across LDP and LHDP. For
each of the cost categories examined, LDP was less costly than
LHDP, although the differences were not significant (Table 6).
However, the TVC for the entire index hospital stay for LDP was
US$1510 lower than that for LHDP, demonstrating a statistically
significant difference (US$10 030 versus US$11 540; P = 0.048).
Furthermore, when the TVCs of the 49 LDP cases (excluding the
21 hand-assisted cases) were compared with those of the 45 ODP
cases, the total cost of the index hospital admission was found to
be statistically significantly lower in LDP than in ODP (US$10 030
versus US$13 900; P = 0.03).
Discussion
As a result of improvements in technology and growing surgeon
experience, the performance of LDP continues to increase. The
present study sought to establish a comprehensive cost compari-
son analysis between open and laparoscopic DP in well-matched
patients at a high-volume academic centre.
The current results demonstrate that in well-selected patient
populations, LDP can be performed safely with complication rates
similar to those observed after open procedures. Although it is
associated with higher operative costs than ODP, LDP has a lower
overall cost as a result of the decreased hospital LoS. The increases
in OR costs in laparoscopic cases were largely accounted for by the
use of expensive energy dissection equipment that was not rou-
tinely utilized in open cases.
In order to strengthen the clinical applicability of the present
analysis, left-sided pancreatic resections, both open and
laparoscopic, were stratified according to operative complexity.
This allowed for more effective matching of surgical complexity,
and the validity of this approach was supported by results dem-
onstrating comparable patient demographics, preoperative
laboratory values, and comorbidity indices across the LDP and
ODP cohorts.
Recent meta-analyses of comparisons of operative times for
LDP and ODP in the published literature have not demonstrated
statistically significant differences.3–6,20 In one such meta-analysis
of 18 studies involving 1814 patients, the laparoscopic approach
added an additional 19.71 min to the time required for the open
technique.3 The present results support these conclusions as LDP
procedures required an additional 9 min of operative time on
average. Surgeon expertise and careful patient selection are likely
to contribute to this comparability of operative times. Other
operative results demonstrated equivalence between the two
cohorts. Traditionally, LDP has been used for smaller, benign
tumours or indolent malignancies. In an analysis of 360 DPs,
DiNorcia et al. reported a shorter mean ± standard deviation
average length of pancreas resected (7.7 ± 3.2 cm versus 10.0 ±
3.6 cm; P < 0.01) and a smaller median tumour size of 2.5 cm
[interquartile range (IQR) 1.5–4.0 cm] versus 3.6 cm (IQR 2.0–
6.0 cm) (P < 0.01) in patients operated by LDP compared with
those submitted to ODP.21 In that series, the laparoscopic
approach was used significantly less often in patients with adeno-
Table 5 Intraoperative and postoperative results of laparoscopic and
laparoscopic hand-assisted distal pancreatectomies
LDP (n = 49) LHDP (n = 21) P-value
Estimated blood loss, ml,
mean ± SD
76 ± 71 197 ± 244 0.04
Length of surgery, min,
mean ± SD
138.40 ± 62.8 160.2 ± 55.8 0.19
Intraoperative transfusion,
n (%)
0 1 (5%) 0.66
Drains placed, n (%) 44 (90%) 19 (90%) 1.00
Tumour size, cm,
mean ± SD
3.07 ± 2.34 5.15 ± 3.30 <0.01
Size of pancreas removed,
cm, mean ± SD
9.84 ± 3.21 9.70 ± 2.89 0.85
Number of LNs recovered,
mean ± SD
7.3 ± 7.75 8.14 ± 8.45 0.69
Morbidity, n (%) 22 (41%) 12 (58%) 0.50
Severe morbidity (Clavien
score 3–5), n (%)
6 (12%) 2 (10%) 1.00
Pancreatic fistula (all
grades), n (%)
15 (31%) 10 (48%) 0.28
Grade B/C fistula, n (%) 6 (12%) 4 (19%) 0.71
Hospital LoS, days,
mean ± SD
5.1 ± 2.1 5.6 ± 3.1 0.42
Hospital LoS, days,
median (range)
5 (1–14) 5 (3–18) NA
30-day readmissions,
n (%)
6 (12%) 3 (14%) 1.00
P-values in bold indicate differences of statistical significance (P < 0.05).
LDP, laparoscopic distal pancreatectomy; LHDP, laparoscopic hand-
assisted distal pancreatectomy; SD, standard deviation; LN, lymph
nodes; LoS, length of stay; NA, not applicable.
Table 6 Cost comparisons for laparoscopic and laparoscopic hand-
assisted distal pancreatectomies
Total variable cost, US$,
mean ± SD
LDP (n = 49) LHDP (n = 21) P-value
Index hospital stay 10 030 ± 2610 11 540 ± 3500 0.05
Floor 2540 ± 1280 2690 ± 1580 0.65
Operating room 5510 ± 1300 6340 ± 2790 0.09
Laboratory/pathology 730 ± 330 940 ± 590 0.06
Pharmacology 690 ± 350 780 ± 460 0.42
Radiology 70 ± 150 230 ± 670 0.11
Intensive care unit 140 ± 800 230 ± 730 0.66
Index + readmission: all
patients
10 840 ± 4490 11 730 ± 3540 0.42
Readmissions only 6590 ± 7770 1990 ± 490 0.46
P-values in bold indicate differences of statistical significance (P < 0.05).
SD, standard deviation; LDP, laparoscopic distal pancreatectomy; LHDP,
laparoscopic hand-assisted distal pancreatectomy.
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carcinoma (4% versus 30%; P < 0.01).21 In the current series,
average tumour size and the percentage of resections performed
for adenocarcinoma did not differ significantly between the LDP
and ODP cohorts.
Postoperatively, the LDP and ODP cohorts exhibited similar
rates of complications and comparable severity of morbidity, a
pattern reflected in previous publications.3,5,8,21,22 In their meta-
analysis of 18 studies comparing LDP versus ODP, Venkat et al.
reported an average rate of postoperative morbidity in the LDP
group (n = 780) of 33%, compared with 44% in the ODP cohort
(n = 1034).3 Notably, rates of POPF were nearly identical between
the LDP and ODP cohorts in the present study, including those of
clinically significant (Grades B and C) fistulae.
Consistent with previous studies, the present study showed a
significant decrease in hospital LoS in the LDP group. This can
probably be attributed to earlier weaning from i.v. pain medica-
tion, earlier return of bowel function, and earlier ambulation. In a
multicentre analysis of 637 DPs, which included 159 laparoscopic
procedures, the Central Pancreas Consortium (CPC) demon-
strated a significantly shorter hospital LoS in the LDP group com-
pared with the ODP group (5.9 days versus 9.0 days; P < 0.01).8 An
important aspect of this earlier work is that five of the eight
participating centres in this study did not use a laparoscopic
approach and thus the comparison is more likely to be valid.
Other authors have shown similar trends, with decreases of 2.7–
5.0 days in hospital LoS for LDP compared with ODP.3,5,23
The decrease in the average hospital stay in the LDP cohort
appears to be the driving factor in the cost disparity between LDP
and ODP in the present series. In the current analysis, the costs of
perioperative care for patients in the LDP cohort were lower in
each of the defined cost categories. Decreased hospital LoS
appears to uniformly drive down all costs associated with the
postoperative management of LDP patients. In a detailed cost
analysis of LDP versus ODP at a high-volume Canadian centre,
Fox et al. reported similar findings with regard to the contribution
made by a decrease in hospital LoS to the lowering of the total
costs of LDP.12 The results of that study demonstrated a linear
relationship between hospital LoS and total cost, in concordance
with the present findings. The implication is that factors tradi-
tionally associated with laparoscopic surgery, such as decreased
postoperative pain and early ambulation, also promote a lower
cost of care by earlier patient discharge. Although the cost differ-
ence per patient between LDP and ODP in the index hospital
admission did not reach statistical significance, when the total
costs of index and 30-day readmissions are factored into the
analysis, LDP emerges as significantly less costly. As both cohorts
had similar rates of 30-day readmission, the explanation for
this cost differential may lie in the nature of postoperative
complications or reasons for readmission. Readmission after pan-
creatic surgery has been subject to previous investigation. In a
multi-institution study of 1302 patients submitted to
pancreaticoduodenectomy, Ahmad et al. examined factors influ-
encing readmission rates for that procedure.24 They found that
higher readmission rates were associated with a preoperative diag-
nosis of chronic pancreatitis, higher transfusion requirements,
and postoperative complications including intra-abdominal
abscess and pancreatic fistula (all: P < 0.02).24 In their conclusion,
the authors noted that factors related to infection, delayed gastric
emptying, and the optimization of nutrition were the most
common reasons for readmission in the 30- and 90-day periods.24
In the present series, the most common cause for readmission
within 30 days of surgery in both the ODP and LDP cohorts was
infection-related (n = 4 in the ODP group; n = 5 in the
LDP group). A more detailed analysis of readmission was beyond
the scope of the current analysis, but is an area of ongoing
investigation.
The present analysis of LHDP versus LDP showed that
intraoperative blood loss and tumour resection size were
decreased in purely laparoscopic cases. Although the subcatego-
ries of costs did not differ significantly between LDP and LHDP,
LDP showed an overall cost advantage because the total cost of
care for an LDP patient was US$1500 lower than that for an LHDP
patent. As hospital LoS was similar in both groups, this cost dis-
parity reflects small differences that are likely to relate to the
increased complexity of hand-assisted cases.When the hand-assist
procedures were removed from analysis and data for the 49 LDP
procedures were compared directly with data for the 45 ODP
procedures, the TVC for the index hospitalization was found to be
significantly (US$3900) lower in LDP (P = 0.03). Other retrospec-
tive series and one case–control study have examined the cost-
effectiveness of LDP and most studies have demonstrated no
significant difference in the total cost of care in LDP compared
with ODP (Table 7). In a Canadian series, the authors excluded
multiple organ resections (stomach, colon, kidney) and focused
on DP with or without splenectomy in a manner similar to the
stratification used in the present study.12 Their perioperative and
cost findings were similar to those of the present study, although
their analysis did not include readmissions. Limongelli et al. simi-
larly excluded complicated procedures but found the two surgical
approaches to be cost neutral overall.7 A Korean case–control
study reported a significantly higher total cost of care associated
with LDP.13 These data should be interpreted with caution,
however, as the hospital LoS for patients in both the LDP and
ODP cohorts was significantly longer than in any other published
report (11.5 ± 4.1 days for LDP, 13.5 ± 4.9 days for ODP).13
Additionally, no breakdown of operative and postoperative costs
was included in the Korean analysis.13
Other recent cost analyses comparing laparoscopic and
open surgical procedures have supported the cost-effectiveness
of laparoscopic procedures. An extensive literature review
by Park et al. comparing the costs of 949 laparoscopic partial
nephrectomies (LPNs) with those of 574 open partial
nephrectomies found that minimally invasive procedures accrued
greater costs in the OR as a result of the use of equipment such as
trocars and shears, and haemostasis agents.25 However, the overall
cost of care for LPN was offset by a significantly shorter hospital
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LoS (2.9 days versus 5.7 days; P < 0.01), which led the authors to
conclude that LPN is a more cost-effective approach.25 Nguyen
et al. reported similar findings in their analysis of 79 laparoscopic
gastric bypasses and 76 open bypass procedures conducted within
the UK health care system.26 Patients in the laparoscopic group
experienced lower operative blood loss and a shorter hospital LoS,
and accrued lower overall hospital costs despite higher OR costs.26
The present detailed analysis of equipment expenditures
showed that the use of energy devices (the Harmonic Scalpel and
the Autosonix Ultrasonic Surgical System) was universal in the
laparoscopic cohort and that the average number of devices used
in LDP totalled three times that employed in open procedures.
These devices cost on average an additional US$500 per case and
represent the principal factors contributing to the higher costs of
laparoscopic cases. However, surgical stapler use was higher in the
ODP group, in which high numbers of stapler reloads represented
the major cost burden. The increased use of staplers in open cases
may possibly reflect larger pancreatic specimen resections that
require more firings to adequately seal the remnant. Increased
surgeon awareness of the contributions to costs made by the use of
these energy devices and multiple staple reloads may represent a
strategy for reducing OR costs.
The limitations of the present study include its retrospective
nature and the potential for selection bias. The system used to
stratify DP cases as being of ‘standard’ versus ‘high’ complexity
based on technical difficulty was subjective and was based on the
analysis of operative notes. Similar classification schemes have
been employed previously and all cases were reviewed indepen-
dently by two authors to standardize stratification. Another inher-
ent limitation of this analysis, as with all other published series on
LDP and ODP, is the lack of randomization; some patient selec-
tion bias may have occurred as some of the comparison ODP cases
may not have been suitable for a laparoscopic approach. The
present study encompassed several surgeons with different OR
techniques and equipment preferences, which may have contrib-
uted to the variability seen in the cost analysis of OR device use.
The present study did not include a robust analysis of indirect
costs such as surgeons’ professional fees. These were difficult to
ascertain and were excluded. The authors instead relied on direct
costs and itemized expense reports for each patient’s admission,
sourced from hospital departments, in order to assemble cost
data. Personnel fees were included in some of the cost data (e.g.
ward fees included nursing fees, and occupational therapy
included professional fees), but this was not universal (e.g. labora-
tory worker fees were not included in laboratory costs).
Conclusions
Laparoscopic DP is best suited to patients in whom tumours are
contained in the body and tail of the pancreas, and appears to
provide outcomes similar to those of open resection, with no
increase in complications, lower blood loss, and shorter hospital
stays for cases of similar difficulty. For appropriately selected
patients, the laparoscopic approach to DP appears to be more
cost-effective than the open approach and was associated with
lower costs for index hospital admissions and readmissions. The
increased OR cost associated with LDP is offset by the shorter
hospitalization and lower overall cost of care. These data provide
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